Same Indication

Insulin Glargine vs Tofacitinib

Insulin Glargine vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Insulin Glargine and Tofacitinib.

Mechanism of Action

Insulin Glargine: Long-acting insulin analogue that binds insulin receptors.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Insulin Glargine — 12-24 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Tofacitinib — C16H20N6O.

Molecular Weight: Tofacitinib — 312.3700 g/mol.

Type: Insulin Glargine — Protein; Tofacitinib — Small molecule.